Login or Sign Up
16:01 Mar 06
Rekvina Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Rekvina Laboratories Ltd. Financials
Rekvina Laboratories Ltd.
Industry Pharmaceuticals
16:01 Mar 06
Quality
0/100
Not Eligible
Valuation
1/100
Expensive Valuation
Technical
72/100
Technically Bullish
Strength
7
Weakness
5
Opportunity
0
Threats
0
-5.65 %
ROE %
-421.84 %
ROA %
0.00
EPS
-0.55
BVPS
0.00 %
Net Profit Margin
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | ||
|---|---|---|---|---|---|---|
| Net Sales | 0 | 0 | 0 | 0 | 0 | |
| Operating Expenses + | 0.06 | 0.08 | 0 | 0.02 | 0.14 | |
| Raw Material | 0 | 0 | 0 | 0 | 0 | |
| Increase Decrease in Cost | 0 | 0 | 0 | 0 | 0 | |
| Other Manufacturing Expense | 0 | 0 | 0 | 0 | 0 | |
| Employee Cost | 0 | 0 | 0 | 0 | 0.04 | |
| Miscellaneous Expenses | 0.06 | 0.08 | 0 | 0.02 | 0.1 | |
| Operating Profit | -0.06 | -0.08 | 0 | -0.02 | -0.14 | |
| Other Income | 0 | 0 | 0 | 0 | 0 | |
| Depreciation | 0 | 0 | 0 | 0 | 0 | |
| Interest | 0 | 0 | 0 | 0 | 0 | |
| Profit before tax and exceptio.. | -0.06 | -0.08 | 0 | -0.02 | -0.14 | |
| Exceptional Items | 0 | 0 | 0 | 0 | 0 | |
| PBT | -0.06 | -0.08 | 0 | -0.02 | -0.14 | |
| Provision for Taxation | 0 | 0 | 0 | 0 | 0 | |
| Net Profit | -0.06 | -0.08 | 0 | -0.02 | -0.14 | |
| NET Profit after MI | 0 | 0 | 0 | 0 | 0 | |
| EPS | -0.11 | -0.13 | 0 | -0.03 | -0.23 | |
| Operating Profit Margin (%) | 0 | 0 | 0 | 0 | 0 | |
| Net Profit Margin (%) | 0 | 0 | 0 | 0 | 0 |
Rekvina Laboratories Ltd. Shareholding
All Data in Percentage (%)
| Promoter | - | - | - | - | - |
| FII | - | - | - | - | - |
| Public | - | - | - | - | - |
| MF | - | - | - | - | - |
| Others |
| Shareholder | Shares | Holding % |
|---|
Download Our App On:
Back
OTP sent to your mobile number. Please enter it below to verify.
Verify Email OTP
OTP sent to
Dear User, please
complete your profile!
Email ID Already Exists
Location Saved
Successfully
Email Id Verified
Successfully